胃泌素(GT)合成多肽

Synthetic Gastrin (GT)

GAST; GAS; Gastrin component I; Big gastrin; Gastrin component II; Gastrin component III

  • 胃泌素(GT)合成多肽 产品包装(模拟)
  • 胃泌素(GT)合成多肽 产品包装(模拟)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

序列

用法

PBS或其它。

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Homo sapiens (Human,人) 应用(仅供研究使用,不用于临床诊断!)
RPB224Hu01 胃泌素(GT)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
SPB224Hu01 胃泌素(GT)合成多肽 Immunogen; Blocking Peptide.
SPB224Hu02 胃泌素(GT)合成多肽 Immunogen; Blocking Peptide.
CPB224Hu21 胃泌素(GT)卵白蛋白偶联物 Immunogen; SDS-PAGE; WB.
CPB224Hu22 胃泌素(GT)卵白蛋白偶联物 Immunogen; SDS-PAGE; WB.
PAB224Hu02 胃泌素(GT)多克隆抗体 WB; IHC; ICC; IP.
PAB224Hu03 胃泌素(GT)多克隆抗体 WB; IHC; ICC; IP.
PAB224Hu01 胃泌素(GT)多克隆抗体 WB; IHC; ICC; IP.
LAB224Hu81 胃泌素(GT)多克隆抗体(异硫氰酸荧光素标记) WB; IHC; ICC; IF.
LAB224Hu71 胃泌素(GT)多克隆抗体(生物素标记) WB; IHC; ICC.
MAB224Hu22 胃泌素(GT)单克隆抗体 WB; IHC; ICC; IP.
CEB224Hu 胃泌素(GT)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.

参考文献

杂志 参考文献
Journal of Diabetes Omeprazole improves the antiobesity and antidiabetic activity of Exendin-4 in db/db mice. [PubMed: 22830490]
Cell reports Liver-Derived Systemic Factors Drive b Cell Hyperplasia in Insulin-Resistant States [PubMed: PMC3655439]
Journal of Pharmacy and Pharmacology Lansoprazole enhances the antidiabetic effect of sitagliptin in mice with diet-induced obesity and healthy human subjects [Pubmed: 24628303]
Pharmacological Reports Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice [Pubmed: 24145087]
World J Gastroenterol Roles of sphincter of Oddi motility and serum vasoactive intestinal peptide, gastrin and cholecystokinin octapeptide [NCBI: PMC4000510]
世界华人消化杂志 清醒状态下热射病大鼠胃肠动力与胃泌素、胃动素的变化 [Wjgnet:Source]
World J Gastroenterol Effects of sphincter of Oddi motility on the formation of cholesterol gallstones [Pubmed:27350732]
Nanoscale Engineering bioinspired bacteria-adhesive clay nanoparticles with a membrane-disruptiveproperty for the treatment of Helicobacter pylori infection. [pubmed:27605059]
留言咨询